GRO-α: Biological functions and mechanism analysis of multifunctional chemokines

GRO-α: Biological functions and mechanism analysis of multifunctional chemokines

GRO-α (Growth-Regulated Oncogene-Alpha), also known as CXCL1, is a key member of the CXC chemokine subfamily. It plays a core role in inflammatory response, tissue repair and tumor microenvironment regulation by binding to CXCR1/CXCR2 receptors. This article will systematically analyze the molecular structure, signal transduction mechanism and biological function of GRO-α, and explore its potential role in the occurrence and development of diseases.

Molecular structure and receptor binding characteristics

GRO-α is a small molecule protein composed of 73 amino acids. Its secondary structure contains four conserved cysteine ​​residues, forming two pairs of disulfide bonds, which give it a stable spatial conformation. This chemokine specifically binds to the CXCR1/CXCR2 receptor through the N-terminal domain, triggering downstream signal transduction. CXCR1 has a higher affinity for GRO-α, while CXCR2 shows a wider range of ligand recognition capabilities. This receptor selectivity enables GRO-α to accurately regulate the migration and activation of different cell types.

Signal transduction pathway

After GRO-α binds to the receptor, it activates the G protein-coupled signal transduction cascade. Specifically, CXCR1/CXCR2 inhibits adenylate cyclase activity through Gαi/o protein, reduces intracellular cAMP levels, and activates phospholipase C (PLC) to promote the production of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of calcium ions from the endoplasmic reticulum, and DAG activates protein kinase C (PKC), ultimately regulating gene expression and cell function. In addition, GRO-α can also activate the β-arrestin signaling pathway through a non-G protein-dependent pathway, affecting cytoskeletal reorganization and migration ability.

Biological function

Regulation of inflammatory response: GRO-α is an important mediator of acute inflammation. It promotes the release of inflammatory factors and enhances local immune response by recruiting neutrophils to the site of infection or injury. Its expression level is upregulated by a variety of cytokines (such as IL-1β and TNF-α), forming a positive feedback loop.
Tissue repair and regeneration: During wound healing, GRO-α promotes the proliferation and migration of keratinocytes, fibroblasts, and endothelial cells, accelerating wound closure. It regulates extracellular matrix remodeling by upregulating the expression of matrix metalloproteinases (MMPs), providing a suitable microenvironment for tissue regeneration.
Tumor microenvironment regulation: GRO-α plays a dual role in tumor progression: on the one hand, it supports tumor growth by promoting tumor-associated fibroblast activation and angiogenesis; on the other hand, its induced immune cell infiltration may inhibit tumor progression. This contradictory effect depends on the tumor type and the specific state of the microenvironment.
Potential role and future direction

The regulatory potential of GRO-α in autoimmune diseases, infectious diseases, and tumor treatment has attracted widespread attention. For example, targeted blockade of the GRO-α signaling pathway may inhibit chronic inflammatory responses or enhance the effect of immunotherapy by regulating the tumor microenvironment. Future studies need to further analyze its receptor binding mechanism, signal transduction network, and functional differences across cell types to provide a theoretical basis for the development of new treatment strategies.